Malta - engelska - Malta Medicines Authority

santen oy niittyhaankatu 20, 33720 tampere, finland - timolol, tafluprost - eye drops, solution - timolol 5 mg tafluprost 15 µg - ophthalmologicals

USA - engelska - NLM (National Library of Medicine)

micro labs limited - tafluprost (unii: 1o6wq6t7g3) (tafluprost - unii:1o6wq6t7g3) - tafluprost ophthalmic solution, 0.0015% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. none. pregnancy category c. teratogenic effects: in embryo-fetal development studies in rats and rabbits, tafluprost administered intravenously was teratogenic. tafluprost caused increases in post-implantation losses in rats and rabbits and reductions in fetal body weights in rats. tafluprost also increased the incidence of vertebral skeletal abnormalities in rats and the incidence of skull, brain and spine malformations in rabbits. in rats, there were no adverse effects on embryo-fetal development at a dose of 3 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid that were 343 times the maximum clinical exposure based on c max . in rabbits, effects were seen at a tafluprost dose of 0.03 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid during organogenesis that were approximately 5 times higher than the

USA - engelska - NLM (National Library of Medicine)

sandoz inc - tafluprost (unii: 1o6wq6t7g3) (tafluprost - unii:1o6wq6t7g3) - tafluprost ophthalmic solution 0.0015% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. none. teratogenic effects in embryo-fetal development studies in rats and rabbits, tafluprost administered intravenously was teratogenic. tafluprost caused increases in post-implantation losses in rats and rabbits and reductions in fetal body weights in rats. tafluprost also increased the incidence of vertebral skeletal abnormalities in rats and the incidence of skull, brain and spine malformations in rabbits. in rats, there were no adverse effects on embryo-fetal development at a dose of 3 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid that were 343 times the maximum clinical exposure based on cmax . in rabbits, effects were seen at a tafluprost dose of 0.03 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid during organogenesis that were approximately 5 times higher than the clinical exposure based on cmax . at t

USA - engelska - NLM (National Library of Medicine)

prasco laboratories - tafluprost (unii: 1o6wq6t7g3) (tafluprost - unii:1o6wq6t7g3) - tafluprost ophthalmic solution 0.0015% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. none. pregnancy category c. teratogenic effects: in embryo-fetal development studies in rats and rabbits, tafluprost administered intravenously was teratogenic. tafluprost caused increases in post-implantation losses in rats and rabbits and reductions in fetal body weights in rats. tafluprost also increased the incidence of vertebral skeletal abnormalities in rats and the incidence of skull, brain and spine malformations in rabbits. in rats, there were no adverse effects on embryo-fetal development at a dose of 3 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid that were 343 times the maximum clinical exposure based on cmax . in rabbits, effects were seen at a tafluprost dose of 0.03 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid during organogenesis that were approximately 5 times higher than the clinical exposu

USA - engelska - NLM (National Library of Medicine)

akorn - tafluprost (unii: 1o6wq6t7g3) (tafluprost - unii:1o6wq6t7g3) - tafluprost 0.0045 mg in 0.3 ml - zioptan® (tafluprost ophthalmic solution) 0.0015% is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. none. pregnancy category c. teratogenic effects: in embryo-fetal development studies in rats and rabbits, tafluprost administered intravenously was teratogenic. tafluprost caused increases in post-implantation losses in rats and rabbits and reductions in fetal body weights in rats. tafluprost also increased the incidence of vertebral skeletal abnormalities in rats and the incidence of skull, brain and spine malformations in rabbits. in rats, there were no adverse effects on embryo-fetal development at a dose of 3 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid that were 343 times the maximum clinical exposure based on cmax . in rabbits, effects were seen at a tafluprost dose of 0.03 mcg/kg/day corresponding to maternal plasma levels of tafluprost acid during organogenesis that were approximately 5 times higher than the cli

Japan - engelska - すりの適正使用協議会 RAD-AR Council, Japan

santen pharmaceutical co.,ltd. - tafluprost/timolol maleate - limpid and colorless, ophthalmic solution, 2.5ml, (bottle) clear and colorless, (cap) deep orange

Japan - engelska - すりの適正使用協議会 RAD-AR Council, Japan

nitto medic co., ltd. - tafluprost/timolol maleate - limpid and colorless, aqueous ophthalmic solution, 2.5 ml, (cap) deep brown, (label) white label with deep brown band and line, light blue-green line, (bottle) clear

Filippinerna - engelska - FDA (Food And Drug Administration)

santen pharmaceutical co., ltd.; importer: santen philippines inc.; distributor: santen philippines inc. - tafluprost , timolol maleate - ophthalmic solution - 15mcg/ 5mg/ ml

Australien - engelska - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - tafluprost, quantity: 0.015 mg/ml - eye drops - excipient ingredients: polysorbate 80; glycerol; sodium hydroxide; monobasic sodium phosphate dihydrate; water for injections; disodium edetate; hydrochloric acid - saflutan is indicated for the reduction of elevated intraocular pressure in open-angle glaucoma or ocular hypertension, as monotherapy or as adjunctive therapy to beta blockers.

Kanada - engelska - Health Canada

purdue pharma - tafluprost - solution - 4.5mcg - tafluprost 4.5mcg - prostaglandin analogs